stockrowOrchestra BioMed Holdings, Inc. (OBIO) vs Surrozen, Inc. (SRZN)
- Orchestra BioMed Holdings, Inc. OBIO 5.68 +1.07%
- Surrozen, Inc. SRZN 31.15 +7.41%
Orchestra BioMed Holdings, Inc. and Surrozen, Inc. are both Biotechnology companies. Orchestra BioMed Holdings, Inc. and Surrozen, Inc. are of similar size ($340.9M and $337.8M). Orchestra BioMed Holdings, Inc. grew revenue faster over the last twelve months: 986.1% against −8.79%. Orchestra BioMed Holdings, Inc. has the higher net margin (−186.3% vs −2,887.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Orchestra BioMed Holdings, Inc. leads on 10 and Surrozen, Inc. on 5.
Valuation
Profitability
| Metric | OBIO | SRZN | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.51% | 100.00% | 68.51% |
| Operating margin | (181.36%) | (385.28%) | 0.00% |
| Net margin | (186.30%) | (2,887.07%) | 0.00% |
| Free cash flow margin | (184.83%) | (303.92%) | 0.00% |
| Return on equity | (607.32%) | 387.44% | (51.96%) |
| Return on assets | (75.16%) | (304.47%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack